Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-03T02:46:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    An NIH announcement appears above the study record, describing the website transition and the shift from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    0.5%
    Check dated 2026-10-27T03:21:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-20T05:23:57.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-13T07:59:19.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's Record History, and the previous revision v3.6.6 was removed.
    Difference
    0.1%
    Check dated 2026-09-22T02:47:36.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.6, was added to the history, while Revision: v3.6.5 was removed. This reflects an update to the study record's revision metadata.
    Difference
    0.1%
    Check dated 2026-08-31T23:12:36.000Z thumbnail image

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.